Parametrica Management LTD Amarin Corp Plcuk Transaction History

Parametrica Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.26 - $6.5 $56,913 - $86,840	-13,360 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $3.24 Million - $5.67 Million	-643,786 Reduced 97.97%	13,360 $85,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $2.65 Million - $3.49 Million	657,146 New	657,146 $3.21 Million
Q1 2019 May 07, 2019	SELL	$12.61 - $22.33 $157,625 - $279,125	-12,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $155,125 - $287,250	12,500 New	12,500 $170,000

187

77.1M

247K

121K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $250M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.